ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
Main Authors: | YiHong, S, Bethel, M, Holman, R, Sourij, H, Harrison, P, Tucker, L, Kennedy, I, White, S, Hill, L, Oulhaj, A, Coleman, R, Hu, D |
---|---|
Format: | Journal article |
Published: |
2013
|
Similar Items
-
Randomized controlled trial comparing impact on platelet reactivity of twice‐daily with once‐daily aspirin in people with type 2 diabetes
by: Bethel, M, et al.
Published: (2016) -
SIMPLE AND RATIONAL TWICE-DAILY INSULIN REGIME
by: Turner, R, et al.
Published: (1978) -
Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial
by: Musiime, V, et al.
Published: (2016) -
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial.
by: Connolly, M, et al.
Published: (2009) -
Characteristics of patients needing basal insulin to be given twice-daily or a second insulin formulation during the first year of the 4-T Trial
by: Levy, J, et al.
Published: (2008)